Diabetes Care 19 , 468471 (1996)
The refined TED outcome, which focuses on pathognomonic manifestations, followed the same trend, showing a protective effect at all time points, including a one-year risk of 0.42% in the GLP-1 group compared to 0.53% in the control group (HR 0.79)
GLP-1RAs are being studied for their significant associations with reduced risks of various cardiovascular diseases, neuropsychiatric or substance use disorders, infectious illnesses and respiratory conditions, indicating their potential for broader therapeutic applications [111]
The most common side effects are gastrointestinal
Wegovy is generally available only through private practitioners, and the GKV does not reimburse it for weight management
Once weight stabilises and thyroid function remains consistent, monitoring can return to annual reviews